Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (original) (raw)

• Hodgkin, T. On some morbid appearances of the absorbant glands and spleen. Med.-Chir. Trans. 17, 68–114 (1832).
  Article CAS Google Scholar
• Sternberg, C. Über eine eigenartige unter dem Bilde der Pseudoleukamie verlaufende Tuberculose des lymphatischen Apparates. Heilk 19, 21–90 (1898).
  Google Scholar
• Reed, D. M. On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis. Johns Hopkins Hosp. Rep. 10, 133–196 (1902).
  Google Scholar
• Rosenberg, S. A. Classification of lymphoid neoplasms. Blood 84, 1359–1360 (1994).
  CAS PubMed Google Scholar
• Harris, N. L. et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84, 1361–1392 ( 1994).
  CAS Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project : A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89, 3909–3918 (1997).
  Google Scholar
• Vose, J. M. Current approaches to the management of non-Hodgkin's lymphoma. Semin. Oncol. 25, 483–491 (1998).
  CAS PubMed Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N. Engl. J. Med. 329, 987– 994 (1993).
  Article Google Scholar
• Klein, U. et al. Somatic hypermutation in normal and transformed human B cells. Immunol. Rev. 162, 261–280 (1998).
  Article CAS Google Scholar
• Schena, M., Shalon, D., Davis, R. W. & Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470 ( 1995).
  Article ADS CAS Google Scholar
• Bubendorf, L. et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J. Natl Cancer Inst. 91, 1758–1764 ( 1999).
  Article CAS Google Scholar
• Wang, K. et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229, 101– 108 (1999).
  Article CAS Google Scholar
• Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 , 531–537 (1999).
  Article CAS Google Scholar
• Khan, J. et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58, 5009– 5013 (1998).
  CAS Google Scholar
• Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212–217 (1999).
  Article ADS CAS Google Scholar
• DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457– 460 (1996).
  Article CAS Google Scholar
• Alon, U. et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl Acad. Sci. USA 96, 6745– 6750 (1999).
  Article ADS CAS Google Scholar
• Alizadeh, A. et al. The Lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harbor Symp. Quant. Biol. (in the press).
• Alizadeh, A., Eisen, M., Botstein, D., Brown, P. O. & Staudt, L. M. Probing lymphocyte biology by genomic-scale gene expression analysis. J. Clin. Immunol. 18, 373–379 (1998).
  Article CAS Google Scholar
• Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863– 14868 (1998).
  Article ADS CAS Google Scholar
• Grogan, T. M. et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 71, 1157–1160 (1988).
  CAS PubMed Google Scholar
• Staudt, L. M., Dent, A. L., Shaffer, A. L. & Yu, X. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. J. Immunol. 18, 381–403 (1999).
  CAS Google Scholar
• Bahler, D. W. & Levy, R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl Acad. Sci. USA 89, 6770–6774 (1992).
  Article ADS CAS Google Scholar
• Liu, Y. -J. & Banchereau, J. in Handbook of Experimental Immunology (eds Weir, D., Blackwell, C., Herzenberg, L. & Herzenberg, L.) 93.1–93.9 (Blackwell Scientific, Oxford, 1996).
  Google Scholar
• Golay, J., Erba, E., Bernasconi, S., Peri, G. & Introna, M. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines. J. Immunol. 153, 543–553 ( 1994).
  CAS PubMed Google Scholar
• Kuo, F. C. & Sklar, J. Augmented expression of a human gene for 8-oxoguanine DNA glycosylase (MutM) in B lymphocytes of the dark zone in lymph node germinal centers. J. Exp. Med. 186, 1547–1556 (1997).
  Article CAS Google Scholar
• Flenghi, L. et al. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am. J. Pathol . 147, 405–411 ( 1995).
  CAS PubMed PubMed Central Google Scholar
• Pittaluga, S. et al. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. J. Pathol. 179, 145–150 (1996).
  Article CAS Google Scholar
• Zani, V. J. et al. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24. 1;q32. 3;q24. 1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood 87, 3124 –3134 (1996).
  CAS PubMed Google Scholar
• Fukuda, T. et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186, 439– 448 (1997).
  Article CAS Google Scholar
• Ye, B. H. et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Genet. 16, 161–170 (1997).
  Article CAS Google Scholar
• Dent, A. L., Shaffer, A. L., Yu, X., Allman, D. & Staudt, L. M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276, 589–592 (1997).
  Article CAS Google Scholar
• Rabbitts, T. H. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev. 12, 2651–2657 ( 1998).
  Article CAS Google Scholar
• Iida, S. et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nature Genet. 17, 226– 230 (1997).
  Article CAS Google Scholar
• Matsuyama, T. et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23, 2127–2136 (1995).
  Article CAS Google Scholar
• Mittrucker, H. W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540–543 (1997).
  Article CAS Google Scholar
• Tschopp, J., Irmler, M. & Thome, M. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10, 552–558 ( 1998).
  Article CAS Google Scholar
• Djerbi, M. et al. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190, 1025–1031 ( 1999).
  Article CAS Google Scholar
• Medema, J. P., de Jong, J., van Hall, T., Melief, C. J. M. & Offringa, R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190, 1033–1038 (1999).
  Article CAS Google Scholar
• Fisher, R. I. et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 328, 1002–1006 ( 1993).
  Article CAS Google Scholar
• Jalkanen, S., Joensuu, H., Soderstrom, K. O. & Klemi, P. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest. 87, 1835–1840 (1991).
  Article CAS Google Scholar
• Harada, S. et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5-, and CD5- with CD10+ groups may constitute clinically relevant subtypes. Leukemia 13, 1441– 1447 (1999).
  Article CAS Google Scholar
• Kramer, M. H. et al. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J. Clin. Oncol. 14, 2131–2138 ( 1996).
  Article CAS Google Scholar
• Preti, H. A. et al. Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Ann. Int. Med. 127, 186– 194 (1997).
  Article CAS Google Scholar
• Gascoyne, R. D. et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90, 244–251 ( 1997).
  CAS Google Scholar
• Kramer, M. H. et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 92, 3152–3162 (1998).
  CAS Google Scholar
• Klein, U., Rajewsky, K. & Kuppers, R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188, 1679– 1689 (1998).
  Article CAS Google Scholar
• Tangye, S. G., Liu, Y. J., Aversa, G., Phillips, J. H. & de Vries, J. E. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188, 1691–1703 (1998).
  Article CAS Google Scholar
• Allman, D. et al. BCL-6 expression during B-cell activation. Blood 87, 5257–5268 (1996).
  CAS Google Scholar
• Eisen, M. B. & Brown, P. O. DNA arrays for analysis of gene expression. Methods Enzymol. 303, 179– 205 (1999).
  Article CAS Google Scholar